How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,112 results for

Depression Screening Tools

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Depression

can cause motor retardation). complex care packages; many staff involved and lack of continuity. Assessment tools: A number of assessment tools are available. In primary care, the PHQ-9 can be used as a screening tool. The brief Edinburgh Depression Scale is suited to palliative care patients. The Hospital Anxiety and Depression questionnaire is widely available but focuses on physical symptoms so may be less helpful in this context. Management General In mild depression, psychological support can (...) cancers (more common). Additional barriers to diagnosis exist and include: patient/family feeling that a “fighting spirit” is needed to maximise active treatment/ support from health professionals. difficulty deciding whether depression is a primary problem or reflects suboptimal symptom control concerns about polypharmacy and drug interactions. other physical/ psychological conditions mimicking depression. exclude hypoactive exclude hypothyroidism screen for dementia review medication ( haloperidol

2018 Scottish Palliative Care Guidelines

102. Prevention and early intervention for adults with mild to moderate depression

Prevention and early intervention for adults with mild to moderate depression Prevention and early intervention for adults with mild to moderate depression d An Evidence Check rapid review brokered by the Sax Institute for Beyond Blue. December 2018. An Evidence Check rapid review brokered by the Sax Institute for Beyond Blue. December 2018. This report was prepared by: Frances Kay-Lambkin, Jayden Gilbert, Lauren Pedemont, Matthew Sunderland, Hazel Dalton, Tonelle Handley, Sally Chan, David (...) @saxinstitute.org.au Phone: +61 2 91889500 Suggested Citation: Kay-Lambkin F, Gilbert J, Pedemont L, Sunderland M, Dalton H et al. Prevention and early intervention for people aged 18 and over with, or at risk of, mild to moderate depression and anxiety: An Evidence Check rapid review brokered by the Sax Institute (www.saxinstitute.org.au) for Beyond Blue, 2018. Disclaimer: This Evidence Check Review was produced using the Evidence Check methodology in response to specific questions from the commissioning agency

2018 Sax Institute Evidence Check

103. Management of Major Depressive Disorder (2nd Ediiton)

in acute and continuation phase treatment of major depressive disorder. MAJOR DEPRESSIVE DISORDER IN PERINATAL WOMEN • Screening for perinatal depression may be done in a two-stage approach. ? Use brief screening tools e.g. Patient Health Questionnaire-2 or Whooley Questions in the first stage. ? If there is positive response to the brief screening tools, Edinburgh Postnatal Depression Scale should be used for further screening • For mild to moderate perinatal depression, psychotherapy, e.g (...) • chronic diseases • obesity • chronic pain (e.g. backache, headache) • impoverished home environment • financial constraint • experiencing major life changes • pregnant or postpartum period • socially-isolated • multiple vague symptoms • sleep disturbance • substance abuse (e.g. alcohol, illicit drugs) • loss of interest in sexual activity • old age • There is insufficient evidence to perform screening for depression in the general population. The common tools used in Malaysia for screening

2019 Ministry of Health, Malaysia

104. Standardized Library of Depression Outcome Measures

and to obtain higher degrees of followup. Additional measurements outside of the windows listed above are recommended as supplemental measures. Events of Interest Adverse Events Depression treatment-related adverse events. Use of a brief, publicly available, validated measurement tool to capture adverse events is recommended. Reported in 12-month intervals. Events of Interest Suicide Ideation & Behavior Selection of "several days," "more than half the days," or "nearly every day" option on PHQ-9 item 9 (...) Standardized Library of Depression Outcome Measures Standardized Library of Depression Outcome Measures | Effective Health Care Program Search Effective Health Care website Submit search Toggle navigation Select site to search Search Effective Health Care website Submit search Standardized Library of Depression Outcome Measures Michelle B. Leavy, M.P.H. Fang Li, MD, M.S. * OM1 On behalf of the Outcome Measures Framework (OMF) Depression Workgroup. Abstract Significant variation exists in both

2019 Effective Health Care Program (AHRQ)

105. Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts

to pharmacotherapy and complementary and alternative treatments. 3 For child and adolescent populations only, the guideline also examines the efficacy of medications, but because other existing guidelines adequately address this for adults, the panel chose not to review this body of evidence. The guideline then addresses harms and burdens of treatment and patient 4 values and preferences. The reviews on which this guideline is based did not specifically address screening for 1 Note that psychotic depression (...) Evidence- Based Practice Center scientists (Gartlehner et al., 2015). The panel supplemented this to fill in APA GUIDELINE FOR THE TREATMENT OF DEPRESSION ES-5 gaps of information with data from several others reviews that met quality criteria based on either an AMSTAR (A Measurement Tool to Assess Systematic Reviews; an instrument used to evaluate systematic reviews and meta-analyses for quality; Shea et al., 2007) review (Cuijpers, Driessen, et al., 2012a; Cuijpers, Koole, et al., 2014b; Cuijpers et

2019 American Psychological Association

106. Incorporating Recognition and Management of Perinatal Depression Into Pediatric Practice

in adolescent and adult women using a validated tool, additional screening for depression is specifically recommended in the postpartum period. The 2017 Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, Fourth Edition recommendations from the AAP also now include screening for maternal depression by the 1-, 2-, 4-, and 6-month well-child visits. On the state level, health care providers, academic centers, Medicaid programs, legislatures, and local professional bodies (...) , including AAP chapters, have been working for decades to incorporate maternal perinatal depression screening with standardized tools into prenatal, postpartum, and periodic well-child visits. Ideally, screening would be conducted within a system of care that also provides access to additional mental health evaluation and treatment when concerns are identified. Although such interdisciplinary integration is not always available or feasible, progress has been made. New Jersey and Illinois (2008) were

2019 American Academy of Pediatrics

107. Perinatal Depression: Preventive Interventions

risk of perinatal depression to counseling interventions. Grade: B Risk Assessment There is no accurate screening tool for identifying who is at risk of perinatal depression and who might benefit from preventive interventions. A pragmatic approach, based on the populations included in the systematic evidence review, would be to provide counseling interventions to women with 1 or more of the following risk factors: a history of depression, current depressive symptoms (that do not reach a diagnostic (...) or gestational diabetes, and complications during pregnancy (eg, preterm delivery or pregnancy loss). In addition, social factors such as low socioeconomic status, lack of social or financial support, and adolescent parenthood have also been shown to increase the risk of developing perinatal depression. However, there is no accurate screening tool for identifying women at risk of perinatal depression and who might benefit from preventive interventions. A pragmatic approach, based on the populations included

2019 U.S. Preventive Services Task Force

108. Depression Following Acute Coronary Syndrome

Physicians and approved by the Board of Directors in March 2019. The guideline was published in the American Family Physician on June 14, 2019. Key Recommendations A standardized depression screening tool (e.g. BDI-II, HADS, GDS, PHQ) should be used to screen for depression in patients who have recently experienced an acute coronary syndrome (ACS) event. In patients who screen positive for depression, further assessment should be performed to confirm the diagnosis of depression Antidepressant medication (...) Depression Following Acute Coronary Syndrome Depression Following Acute Coronary Syndrome -- Clinical Recommendation Welcome Search Search Specify your search AAFP.org Patient Care Clinical Practice Guideline Depression Following Acute Coronary Syndrome Screening and Treatment of Depression Following Acute Coronary Syndrome (Developed by the AAFP, March 2019) The guideline, Screening and Treatment of Depression Following Acute Coronary Syndrome , was developed by the American Academy of Family

2019 American Academy of Family Physicians

109. Measurement, Education and Tracking in Integrated Care (METRIC): use of a culturally adapted education tool versus standard education to increase engagement in depression treatment among Hispanic patients: study protocol for a randomized control trial Full Text available with Trip Pro

Measurement, Education and Tracking in Integrated Care (METRIC): use of a culturally adapted education tool versus standard education to increase engagement in depression treatment among Hispanic patients: study protocol for a randomized control trial Significant mental health disparities exist for Hispanic populations, especially with regard to depression treatment. Stigma and poor communication between patients and their providers result in low use of antidepressant medications and early (...) in primary care settings. Recent recommendations from the U.S. Preventive Services Task Force are that primary care providers screen adult patients for depression only if systems are in place to ensure adequate treatment and follow-up.We are conducting a randomized controlled trial among 150 depressed adult Hispanics in a primary care safety net setting, testing the effectiveness of a culturally appropriate depression education intervention to reduce stigma and increase uptake in depression treatment

2017 Trials Controlled trial quality: uncertain

110. Target-D: a stratified individually randomized controlled trial of the diamond clinical prediction tool to triage and target treatment for depressive symptoms in general practice: study protocol for a randomized controlled trial Full Text available with Trip Pro

Target-D: a stratified individually randomized controlled trial of the diamond clinical prediction tool to triage and target treatment for depressive symptoms in general practice: study protocol for a randomized controlled trial Depression is a highly prevalent and costly disorder. Effective treatments are available but are not always delivered to the right person at the right time, with both under- and over-treatment a problem. Up to half the patients presenting to general practice report (...) symptoms of depression, but general practitioners have no systematic way of efficiently identifying level of need and allocating treatment accordingly. Therefore, our team developed a new clinical prediction tool (CPT) to assist with this task. The CPT predicts depressive symptom severity in three months' time and based on these scores classifies individuals into three groups (minimal/mild, moderate, severe), then provides a matched treatment recommendation. This study aims to test whether using

2017 Trials Controlled trial quality: predicted high

111. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder. (Abstract)

on impaired psychosocial function in MDD.Adults aged 18-65 with moderate-to-severe MDD (n = 100) and age-, sex-, and education-matched healthy controls participated in a cross-sectional study validating the THINC-integrated tool (THINC-it), a cognitive screening tool comprised of objective and subjective measures of cognitive function. Depression severity was assessed using the Montgomery-Åsberg Depression Rating Scale and psychosocial function was assessed using the Sheehan Disability Scale (SDS (...) Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder. Psychosocial impairment represents an important treatment target in major depressive disorder (MDD). The majority of patients with MDD do not regain premorbid levels of psychosocial functioning despite the resolution of core depressive symptoms. This study aimed to investigate the respective effects of cognitive function and depression severity

2017 Journal of Affective Disorders

112. Breast screening: Hologic Affirm Prone Biopsy System

version? 1 1 1 How good was the clinical applications training for tomosynthesis/stereo core needle biopsy provided by the the supplier? 2 1 Would have liked to have seen more cases; would have liked more training with lateral arm (became available later in the evaluation) How do you rate the image handling tools for biopsy? 2 1 How do you rate the ease of using prone affirm equipment for biopsy targetting? 1 2 How do you rate the use of the display screen of the biopsy control module (touchscreen (...) Breast screening: Hologic Affirm Prone Biopsy System NHS Breast Screening Programme Equipment Report Practical Evaluation of the Hologic ® Affirm Prone Biopsy System March 2019 Practical Evaluation of the Hologic Affirm Prone Biopsy System 2 About Public Health England Public Health England exists to protect and improve the nation’s health and wellbeing, and reduce health inequalities. We do this through world-leading science, knowledge and intelligence, advocacy, partnerships and the delivery

2019 Public Health England

113. Covid-19: Recommendations for GDM screening and oral glucose tolerance test (OGTT) during pregnancy and postpartum

Covid-19: Recommendations for GDM screening and oral glucose tolerance test (OGTT) during pregnancy and postpartum Translating evidence into best clinical practice Queensland Health NOTICE OF UPDATE DURING COVID-19 PANDEMIC DATE 14 April 2020 TOPIC Recommendations for GDM screening and oral glucose tolerance test (OGTT) during pregnancy and postpartum APPLIES TO All pregnant and postnatal women irrespective of COVID-19 status RATIONALE During the COVID-19 pandemic • Supports social distancing (...) . there is no requirement to alter request for OGTT if this has already been recommended to the woman) SECTION OF GUIDELINE AFFECTED BY UPDATE • Flowchart: Screening and diagnosis of GDM (updated flow available) • Section 2.5 Testing for GDM (updated) • Section 6.3 Discharge planning (updated) UPDATED RECOMMENDATION All women (irrespective of COVID-19 status) • If clinical features of concern emerge during pregnancy (e.g. macrosomia, fetus accelerating through centiles, other concerns), then recommend usual screening

2020 Queensland Health

114. Unhealthy Drug Use: Screening

. The American Academy of Pediatrics recommends screening adolescents through their early 20s for substance use (including tobacco and alcohol) at every annual physical examination as well as screening adolescents who present to emergency departments or urgent care centers; report cigarette smoking; have depression, anxiety, or other mental health conditions associated with substance abuse; or exhibit school, legal, or social problems or other behavioral changes. It provides a list of screening tools (...) for drug use in adolescents. How to implement this recommendation? For adults: Ask adults about unhealthy drug use. Clinicians can ask the questions or ask their patient to share their answers on a form, computer, or tablet. There are a variety of screening tools available, such as: Brief tools (eg, NIDA [National Institute on Drug Abuse] Quick Screen, which asks 4 questions about use of alcohol, tobacco, nonmedical use of prescription drugs, and illegal drugs in the past year), which may be more

2020 U.S. Preventive Services Task Force

115. What basic tools can be used by any health care professional in primary care for screening of patients with long-term conditions for mental health symptoms (anxiety and depression)?

What basic tools can be used by any health care professional in primary care for screening of patients with long-term conditions for mental health symptoms (anxiety and depression)? What basic tools can be used by any health care professional in primary care for screening of patients with long-term conditions for mental health symptoms (anxiety and depression)? - Trip Database or use your Google+ account Find evidence fast ALL of these words: Title only Anywhere in the document ANY (...) by any health care professional in primary care for screening of patients with long-term conditions for mental health symptoms (anxiety and depression)? The NICE guideline on depression in adults with a chronic physical health problem (1) contains a chapter on the identification of depression in people with a chronic physical health problem. This discusses various screening tools including: the Patient Health Questionnaire, the Beck Depression Inventory, the General Health Questionnaire

2012 TRIP Answers

116. We need better screening tools and outcome measures to develop meaningful predictions of post-surgical pain

We need better screening tools and outcome measures to develop meaningful predictions of post-surgical pain We need better screening tools and outcome measures to develop meaningful predictions of post-surgical pain - The BMJ ---> Patients undergoing elective surgery often attend a pre-assessment clinic where suitability for surgery is determined. Patient Reported Outcome Measures (PROMs) are increasingly used to assess the quality of care delivered to NHS patients and to demonstrate health (...) gains following surgical intervention. [1] There is a body of evidence that establishes the interaction between mental health, surgical intervention, and pain, however conditions such as depression, chronic pain and anxiety are rarely prioritised at the pre-operative assessment. [2] Furthermore, current PROMs do not adequately include a psychological assessment to assess their influence on the postoperative outcome. Many patients who reach the clinic are keen for surgery, but there is a group

2018 The BMJ Blog

117. We need better screening tools and outcome measures to develop meaningful predictions of post-surgical pain

We need better screening tools and outcome measures to develop meaningful predictions of post-surgical pain We need better screening tools and outcome measures to develop meaningful predictions of post-surgical pain - The BMJ ---> Patients undergoing elective surgery often attend a pre-assessment clinic where suitability for surgery is determined. Patient Reported Outcome Measures (PROMs) are increasingly used to assess the quality of care delivered to NHS patients and to demonstrate health (...) gains following surgical intervention. [1] There is a body of evidence that establishes the interaction between mental health, surgical intervention, and pain, however conditions such as depression, chronic pain and anxiety are rarely prioritised at the pre-operative assessment. [2] Furthermore, current PROMs do not adequately include a psychological assessment to assess their influence on the postoperative outcome. Many patients who reach the clinic are keen for surgery, but there is a group

2018 The BMJ Blog

118. Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings

of eye health and vision care, but do not have specialist expertise or access to specialized equipment. It does not seek to address vision screening undertaken by pro- fessional groups with specific expertise in primary vision care, such as optometrists. The screening methods considered included both self-report of vision function and objective vision testing. Self-report included structured survey and questions. For objective testing of visual acuity, although there are several tools available (...) Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings E588 CMAJ | MAY 14, 2018 | VOLUME 190 | ISSUE 19 © 2018 Joule Inc. or its licensors I mpaired vision is an important health burden in both devel- oped and developing countries, particularly among older adults. 1 The 2006 Participation and Activity Limitation Survey found that 13% of Canadians aged 75 years and older had a “see- ing limitation,” with 31% described as severe, compared

2018 CPG Infobase

119. Guidelines for the Evaluation and Treatment of Perimenopausal Depression

of menopausal stage, assessment of co-occurring psychiatric and menopause symptoms, appreciation of the psychosocial factors common in midlife, differential diagnoses, and the use of validated screening instruments. Proven therapeutic options for depression (ie, antidepressants, psychotherapy) are the front-line treatments for perimenopausal depression. Although estrogen therapy is not approved to treat perimenopausal depression, there is evidence that it has antidepressant effects in perimenopausal women (...) is the differential diagnosis of depression during the menopausal transition? 3) What symptoms commonly co- occur with depression in midlife women? 4) What are the unique psychosocial challenges associated with the meno- pause transition that might contribute to depressive symp- toms? and, 5) What screening measures have been validated for assessing depression and depressive symptoms? Studies that were published in a peer-reviewed journal, published in the English language, and utilized a validated or standard

2018 The North American Menopause Society

120. Depression: Adult and Adolescent

by the individual patient. 2 Major Changes as of December 2018 New Previous Recommendations for women who are pregnant, postpartum, or currently on antidepressants and considering pregnancy are now in a separate guideline. Previously, recommendations for pregnant and postpartum women were included in this guideline. For adults, the standalone depression screening tool (PHQ-9) has been replaced by a more expansive Annual Behavioral Health Questionnaire. For adolescents, the PHQ-9A with additional screening (...) questions (ADQ) on the back page remains the recommended tool. Previously, depression screening for adults was done by a standalone PHQ-9 tool with additional depression questions on the back page. Omega-3s and SAMe are considered options for patients who are reluctant to take traditional antidepressants. Previously, omega-3s and SAMe were not recommended for treatment of depression due to insufficient evidence. Bright light therapy is now recommended as a non- pharmacologic option for depression

2017 Kaiser Permanente Clinical Guidelines

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>